Clinical features as potential prognostic factors in patients treated with nivolumab for highly pretreated metastatic gastric cancer: a multicenter retrospective study

BACKGROUND: Although nivolumab (anti-programmed cell death-1 antibody) is a promising approach for advanced gastric cancer (AGC), the response rate remains limited. The aim of this multicenter retrospective study was to determine if clinical features could serve as prognostic factors of the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Sano, Akihiko, Sohda, Makoto, Nakazawa, Nobuhiro, Ubukata, Yasunari, Kuriyama, Kengo, Kimura, Akiharu, Kogure, Norimichi, Hosaka, Hisashi, Naganuma, Atsushi, Sekiguchi, Masanori, Saito, Kana, Ogata, Kyoichi, Sakai, Makoto, Ogawa, Hiroomi, Shirabe, Ken, Saeki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721909/
https://www.ncbi.nlm.nih.gov/pubmed/34980017
http://dx.doi.org/10.1186/s12885-021-09118-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721909/
https://www.ncbi.nlm.nih.gov/pubmed/34980017
http://dx.doi.org/10.1186/s12885-021-09118-3

Ejemplares similares